Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study

BACKGROUND: Glucocorticoids are associated with increased fracture risk and are the mainstay of treatment in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). However, fracture risk in these conditions has not been previously quantified. The aim of this study was to quantify the risk of f...

Descripción completa

Detalles Bibliográficos
Autores principales: Paskins, Zoe, Whittle, Rebecca, Sultan, Alyshah Abdul, Muller, Sara, Blagojevic-Bucknall, Milica, Helliwell, Toby, Hider, Samantha, Roddy, Edward, Mallen, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761155/
https://www.ncbi.nlm.nih.gov/pubmed/29316928
http://dx.doi.org/10.1186/s12916-017-0987-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761155/
https://www.ncbi.nlm.nih.gov/pubmed/29316928
http://dx.doi.org/10.1186/s12916-017-0987-1

Ejemplares similares